Insider Trading Alert - SMG, EWBC And MFRM Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 13, 2014, 88 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $292.00 to $15,496,000.00.

Highlighted Stocks Traded by Insiders:

Scotts Miracle Gro (SMG) - FREE Research Report

Hagedorn Partnership, L.P., who is 10% Owner at Scotts Miracle Gro, sold 124,696 shares at $60.35 on Nov. 13, 2014. Following this transaction, the 10% Owner owned 16.1 million shares meaning that the stake was reduced by 0.77% with the 124,696-share transaction.

The shares most recently traded at $60.82, up $0.47, or 0.78% since the insider transaction. Historical insider transactions for Scotts Miracle Gro go as follows:

  • 4-Week # shares bought: 810
  • 4-Week # shares sold: 70,700
  • 12-Week # shares bought: 810
  • 12-Week # shares sold: 70,700
  • 24-Week # shares bought: 810
  • 24-Week # shares sold: 176,572

The average volume for Scotts Miracle Gro has been 319,700 shares per day over the past 30 days. Scotts Miracle Gro has a market cap of $3.7 billion and is part of the basic materials sector and chemicals industry. Shares are down 3.04% year-to-date as of the close of trading on Thursday.

The Scotts Miracle-Gro Company is engaged in manufacturing, marketing, and selling consumer lawn and garden care products. The stock currently has a dividend yield of 2.97%. The company has a P/E ratio of 22.9. Currently, there are 3 analysts who rate Scotts Miracle Gro a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SMG - FREE

TheStreet Quant Ratings rates Scotts Miracle Gro as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, notable return on equity, increase in net income and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Scotts Miracle Gro Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

East West Bancorp (EWBC) - FREE Research Report

Gouw Julia S, who is President at East West Bancorp, sold 10,000 shares at $37.22 on Nov. 13, 2014. Following this transaction, the President owned 222,823 shares meaning that the stake was reduced by 4.3% with the 10,000-share transaction.

The shares most recently traded at $37.25, up $0.03, or 0.08% since the insider transaction. Historical insider transactions for East West Bancorp go as follows:

  • 4-Week # shares sold: 9,815
  • 12-Week # shares sold: 9,815
  • 24-Week # shares sold: 12,315

The average volume for East West Bancorp has been 629,300 shares per day over the past 30 days. East West Bancorp has a market cap of $5.4 billion and is part of the financial sector and banking industry. Shares are up 6.56% year-to-date as of the close of trading on Thursday.

East West Bancorp, Inc. operates as the bank holding company for East West Bank that provides a range of personal and commercial banking services to small and medium-sized businesses, business executives, professionals, and other individuals. The stock currently has a dividend yield of 1.91%. The company has a P/E ratio of 16.5. Currently, there are 7 analysts who rate East West Bancorp a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EWBC - FREE

TheStreet Quant Ratings rates East West Bancorp as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year, growth in earnings per share, increase in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full East West Bancorp Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Mattress Firm (MFRM) - FREE Research Report

Forbes Karrie, who is Executive Vice President at Mattress Firm, sold 3,000 shares at $68.00 on Nov. 13, 2014. Following this transaction, the Executive Vice President owned 54,942 shares meaning that the stake was reduced by 5.18% with the 3,000-share transaction.

The shares most recently traded at $68.96, up $0.96, or 1.39% since the insider transaction. Historical insider transactions for Mattress Firm go as follows:

  • 4-Week # shares bought: 5,326
  • 4-Week # shares sold: 43,000
  • 12-Week # shares bought: 5,326
  • 12-Week # shares sold: 171,821
  • 24-Week # shares bought: 5,326
  • 24-Week # shares sold: 220,004

The average volume for Mattress Firm has been 188,800 shares per day over the past 30 days. Mattress Firm has a market cap of $2.3 billion and is part of the services sector and specialty retail industry. Shares are up 59.43% year-to-date as of the close of trading on Thursday.

Mattress Firm Holding Corp., through its subsidiaries, operates as a specialty retailer of mattresses, and related products and accessories in the United States. The company has a P/E ratio of 40.2. Currently, there are 9 analysts who rate Mattress Firm a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MFRM - FREE

TheStreet Quant Ratings rates Mattress Firm as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, solid stock price performance, expanding profit margins and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Mattress Firm Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

General Electric Booted From Dow, Replaced by Walgreens

General Electric Booted From Dow, Replaced by Walgreens